SuYvonne Bell, associate director, sales operations at Gilead Sciences, shares her insights on managing a cutting-edge biotech fleet in a post-COVID world. In this conversation with Chris Brown of Automotive Fleet, Bell discusses how she’s redefining traditional fleet practices to better serve her road warriors, improve sustainability, and maintain a competitive edge.
From expanding OEM partnerships to replacing ICE vehicles with hybrids, Bell shares practical strategies and passionate perspectives on what it takes to lead a modern corporate fleet.
🧭 Topics Covered
Gilead Sciences’ core mission and how fleet supports its field operations
Post-COVID fleet rebound: more miles, more usage, renewed focus on safety
Future-proofing the fleet through OEM diversification
Embracing hybrids and long-range EVs in a challenging infrastructure landscape
Replacing ICE vehicles with sustainable alternatives
Strategic overhaul: taking a “blank slate” approach to fleet selectors
The importance of fleet evolution and competitive benchmarking
Why SuYvonne says, “Fleet moves the economy” — and how she lives that mission daily
🎧 Check out the Automotive Fleet podcasts!
Subscribe on Apple Podcasts.
Follow on Spotify.
Check us out on Amazon.
Listen on iHeartRadio.